Transcatheter aortic, mitral, and tricuspid therapies have emerged as important new therapeutic options for patients with valvular heart disease. Integrating non-invasive cardiac imaging, surgical experiences, and novel interventional approaches are required as part of a multidisciplinary heart team approach for diagnosis and planning of optimal treatment approaches to patients with advanced valvular heart disease.
Transcatheter Valve Therapies (TVT) is designed for interventional cardiologists, imaging specialists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals. TVT will provide a comprehensive review of the best clinical practices in the management of valvular heart disease, including in-depth coverage of less invasive transcatheter devices currently in use or under investigation.
TVT 2017 COURSE HIGHLIGHTS
- Live case demonstrations of transcatheter aortic and mitral valve interventions from multiple international sites
- Workshops on clinical controversies and physician training topics
- Poster abstracts and innovative technology sessions
- Bioskills sessions of cardiac anatomy with integrated echo and MSCT imaging
- Challenging case presentations and abstracts from attendees
- A full day structural heart disease imaging workshop (echo, MSCT, and trans-septal techniques)
Program Sponsorship and Support
The activity is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from multiple commercial supporters.
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this live activity for a maximum of 25.5 (subject to change) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance and CME certificates available on the CRF events app and online at cme.crf.org.
- Discuss evaluation and management of patients with valvular heart disease
- Assess the imaging modalities available for diagnosis of valvular heart disease
- Describe current and future therapeutic options for valvular heart disease
- Acquire the skills necessary to perform transcatheter valve therapies
This symposium is designed for interventional cardiologists, imaging specialists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of transcatheter valve therapies.
Evaluation will address content, presentation, possible bias, and future educational needs.
- It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
- Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
- Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.